For the editorial, shorter version of this post, see The Quiet Way I Treat Aging: NAD Plus, GHK-Cu, and the Peptides I Stand Behind on drworldwide.com
[DOI] [PubMed] [Google Scholar] 47.Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R
For patients who cannot tolerate statins or require additional lipid lowering despite maximum tolerated statin therapy, NICE guidance supports several alternative or adjunctive treatments: Ezetimibe : Reduces cholesterol absorption from the intestine and can be used alone or in combination with statins PCSK9 inhibitors (evolocumab, alirocumab): Injectable medications reserved for specific high-risk patients with familial hypercholesterolaemia or established cardiovascular disease who have not achieved targets with other therapies Bempedoic acid : A newer oral option for patients with statin intolerance Inclisiran : An injectable treatment given twice yearly for primary hypercholesterolaemia or mixed dyslipidaemia in line with NICE criteria Icosapent ethyl : For people with established cardiovascular disease and raised triglycerides despite statin therapy Fibrates : Primarily used for severe hypertriglyceridaemia Lifestyle modifications remain fundamental to cholesterol management and should be implemented alongside any pharmacological treatment
Liu, H., Liu, L
Knowing how to identify and reduce symptoms, side effects, and complications before and after surgery may make for an easier experience.
